Michael Newman - Aug 4, 2021 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
CSO and Director, Director, 10%+ Owner
Signature
/s/ Diana Douglas, Attorney-in-Fact
Stock symbol
INDP
Transactions as of
Aug 4, 2021
Transactions value $
$0
Form type
4
Date filed
8/6/2021, 05:00 PM
Previous filing
Aug 6, 2021
Next filing
Jan 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +290K $0.00 290K Aug 4, 2021 Common Stock 290K $8.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-third of the total shares on August 4, 2022 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.